Avacta Group Plc
Avacta Group Plc (AVCTF) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · AVCTF · as of Jun 9, 2026
Key Statistics
Explore Avacta Group Plc Data
avctf stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 1 · Buy rate: 0.0%
Competitors & Peers
avctf competitorsAVCTF
BOVNF
CLVLY
CMVLF
CRLBF
HLOSFStock Performance
Full HistoryAbout Avacta Group Plc
Avacta Group Plc a biopharmaceutical enterprise operating at the clinical stage, was established in 2003 and is headquartered in Wetherby, UK. The company specializes in the creation of cancer treatm…
what is avacta group plc · avctf stock overview · avacta group plc company profile · who is avacta group plc ceo · avctf OTC · avacta group plc headquarters · avacta group plc business segments
About Stock Overview & Key Data
Avacta Group Plc (AVCTF) is a Healthcare company in the Biotechnology industry, listed on OTC since May 22, 2020. As of the latest trading session, AVCTF stock price is $1.00, with a market capitalization of $437.4M. The stock has returned +149.31% over the past 12 months and +28.54% year-to-date.
According to 1 Wall Street analysts, the consensus rating for Avacta Group Plc stock is Sell, with an average 12-month price target of $—. In fiscal year 2025, Avacta Group Plc reported revenue of $112981.00 and net income of -$38.4M. For detailed data — including Avacta Group Plc revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Avacta Group Plc (AVCTF) stock price is $1.00. The stock is traded on OTC under the ticker symbol AVCTF. The 52-week range is $0.40 – $1.23.